Lexaria Bioscience Corp. LEXX
NASDAQ
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 20.00K | -- | 174.00K | 174.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 20.00K | -- | 174.00K | 174.00K |
| Cost of Revenue | -- | -- | -- | 0.00 | -- |
| Gross Profit | -- | 20.00K | -- | 174.00K | 174.00K |
| SG&A Expenses | 1.02M | 996.50K | 902.30K | 766.70K | 1.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.99M | 1.47M | 1.57M | 2.65M | 3.92M |
| Operating Income | -1.99M | -1.45M | -1.57M | -2.47M | -3.75M |
| Income Before Tax | -1.99M | -1.45M | -1.60M | -2.70M | -3.79M |
| Income Tax Expenses | 0.00 | 2.60K | 1.80K | -- | -- |
| Earnings from Continuing Operations | -1.99M | -1.45M | -1.60M | -2.70M | -3.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.80K | 2.80K | 2.50K | 1.40K | 1.50K |
| Net Income | -1.99M | -1.45M | -1.60M | -2.70M | -3.79M |
| EBIT | -1.99M | -1.45M | -1.57M | -2.47M | -3.75M |
| EBITDA | -1.97M | -1.43M | -1.56M | -2.45M | -3.72M |
| EPS Basic | -1.20 | -0.89 | -1.12 | -2.07 | -3.11 |
| Normalized Basic EPS | -0.75 | -0.55 | -0.69 | -1.18 | -1.92 |
| EPS Diluted | -1.20 | -0.89 | -1.12 | -2.07 | -3.11 |
| Normalized Diluted EPS | -0.75 | -0.55 | -0.69 | -1.18 | -1.92 |
| Average Basic Shares Outstanding | 1.65M | 1.63M | 1.43M | 1.31M | 1.22M |
| Average Diluted Shares Outstanding | 1.65M | 1.63M | 1.43M | 1.31M | 1.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |